We are live on ! Find out more
MED icon

Medifast

286 hedge funds and large institutions have $1.7B invested in Medifast in 2022 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 99 increasing their positions, 106 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more capital inflows, than outflows

Capital inflows: $167M | Capital outflows: $147M

1.63% more ownership

Funds ownership: 84.34% → 85.97% (+1.6%)

0% more funds holding in top 10

Funds holding in top 10: 5 → 5 (0)

7% less repeat investments, than reductions

Existing positions increased: 99 | Existing positions reduced: 106

4% less funds holding

Funds holding: 297 → 286 (-11)

20% less first-time investments, than exits

New positions opened: 32 | Existing positions closed: 40

48% less call options, than puts

Call options by funds: $6.93M | Put options by funds: $13.3M

Holders
286
Holders Change
-11
Holders Change %
-3.7%
% of All Funds
4.49%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
32
Increased
99
Reduced
106
Closed
40
Calls
$6.93​M
Puts
$13.3​M
Net Calls
-⁠$6.37​M
Net Calls Change
+$3.94​M

MED Hedge Fund Activity: Q1 2022 in Review

286 of the 6,363 institutional investors tracked by Wall St. Rank reported a position in Medifast (MED) for Q1 2022, worth a combined $1.7B — down 17% from $2.05B a quarter earlier.

Sellers outnumbered buyers: 40 funds closed out of MED and 32 opened new positions — a net loss of 8 holders — while 106 trimmed existing stakes and 99 added.

The largest buyer was BlackRock, adding an estimated $26.1M. The largest seller was Acadian Asset Management, cutting an estimated $17.1M.

  • 286 institutional investors held Medifast (MED) as of Q1 2022, down from 297 in Q4 2021.
  • Funds reported $1.7B of Medifast stock for Q1 2022, down 17% quarter-over-quarter.
  • 32 funds opened new Medifast positions in Q1 2022 and 40 closed out, a net change of -8 holders.
  • The largest Medifast buyer in Q1 2022 was BlackRock, an estimated $26.1M added.
  • The largest Medifast seller in Q1 2022 was Acadian Asset Management, an estimated $17.1M sold.

Based on aggregated 13F filings for Q1 2022.